Concepedia

W. Stephen Faraci

WS

20

Publications

1.1K

Citations

17

H-Index

1984

Active since

Affiliations

Pfizer (United States)(Current)

Wesleyan University

Harvard University

Massachusetts Institute of Technology

W. Stephen Faraci is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1984–1999

20

Publications

20

Subcloning, expression, and purification of the enterobactin biosynthetic enzyme 2,3-dihydroxybenzoate-AMP ligase: demonstration of enzyme-bound (2,3-dihydroxybenzoyl)adenylate product

Frank Rusnak, W. Stephen Faraci, Christopher T. Walsh · Biochemistry · 1989 · 130 citations

Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-<i>d</i>]pyrimidine:  A Centrally Active Corticotropin-Releasing Factor<sub>1</sub> Receptor Antagonist

Yuhpyng L. Chen, Robert S. Mansbach, Steven M. Winter et al. · Journal of Medicinal Chemistry · 1997 · 113 citations · Full text

, , +13

Posttranslational amino acid epimerization: enzyme-catalyzed isomerization of amino acid residues in peptide chains.

Steffen Heck, W. Stephen Faraci, Paul R. Kelbaugh et al. · Proceedings of the National Academy of Sciences · 1996 · 90 citations · Full text

, , +21

Mechanism of inhibition of the PC1 .beta.-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group

W. Stephen Faraci, R. F. Pratt · Biochemistry · 1985 · 77 citations

Mechanism of inactivation of alanine racemase by .beta.,.beta.,.beta.-trifluoroalanine

W. Stephen Faraci, Christopher T. Walsh · Biochemistry · 1989 · 68 citations

Rows per page

1–5 of 20